anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
PROBLEM TO BE SOLVED: To prepare an oily cosmetic having excellent use feeling and storing stability. SOLUTION: This oily cosmetic contains 45-99wt.% liquid oil (e.g. liquid paraffin), 0.1-15wt.% dextrin fatty acid ester (e.g. dextrin palmitate), 0.1-20wt.% nonionic surfactant excepting the dextrin fatty acid ester (e.g. sorbitan monolaurate) and 0.01-20wt.% water as active components. Furthermore, a usual pharmacedynamic agent, a humectant component, an anti-inflammatory drug, a germicide, an antiseptic agent, an ultraviolet rays absorber, an antioxidant, organic or inorganic powder, coloring matter and perfume, etc., are suitably mixed to prepare a cosmetic such as cleansing, massage, essence, hair oil and sun oil. This oily cosmetic is capable of readily coating in contrast to usual oily cosmetics without dropping off in the use.
Brain injury after cardiac surgery is a chief source of patient mortality and healthcare costs and can significantly impair quality of life. Reducing the burden of this complication has wide public health implications. The broad manifestations of perioperative brain injury include stroke, delirium, and cognitive decline.5 All forms of injury are believed to result primarily from cerebral embolism and/or reduced cerebral blood flow (CBF). The risk for cerebral hypoperfusion is likely the highest during cardiopulmonary bypass (CPB), when mean arterial pressure (MAP) is kept low (\~60 mmHg), particularly for patients who are aged and who have cerebral vascular disease. Near-infrared spectroscopy (NIRS) is used increasingly to monitor regional cerebral oxygen saturation (rScO2) in patients undergoing cardiac surgery, although limited data show that it improves patient outcomes. Regardless, clinical evidence supporting the efficacy of NIRS-based monitoring is needed urgently because the cost of NIRS sensors (\~$220/patient) could add $132 million annually to hospital costs for cardiac surgery. We must address this issue quickly because the rising prevalence of NIRS use and advocacy by experts and industry will likely soon result in NIRS becoming a standard of care. We are in the process of submitting a multicenter, prospectively randomized comparative effectiveness trial to assess the efficacy of NIRS monitoring in patients who are undergoing coronary artery bypass graft (CABG) surgery with CPB, and/or valve surgery, and who are at risk for brain injury. The goal of the planned proposal is to determine whether interventions to correct rScO2 desaturations (value \<50% or 20% reduction from room air baseline) reduce the frequency of neurologic and other complications compared with standard care (no clinical monitoring). In order to demonstrate feasibility of our proposal we need to demonstrate the ability of the team to collect rScO2 data from multiple centers and to show the ability of the team to properly follow an algorithm for treating rScO2 desaturations that occur during surgery. Thus, the aim of the current study is to collect preliminary data to support our larger comparative effectiveness trial.
BACKGROUND: Computational linguistics allows an understanding of language structure and different forms of expression of patients' perceptions.
AIMS: The aims of this study were (i) to carry out a descriptive analysis of the discourse of people with chronic low back pain using sentiment analysis (SA) and network analysis; (ii) to verify the correlation between patients' profiles, pain intensity and disability levels with SA and network analysis; and (iii) to identify clusters in our sample according to language and SA using an unsupervised machine learning technique.
METHODS: We performed a secondary analysis of a qualitative study including participants with chronic non-specific low back pain. We used the data related to participants' feelings when they received the diagnosis. The SA and network analysis were performed using the Valence Aware Dictionary and sEntiment Reasoner, and the Speech Graph, respectively. Clustering was performed using the K-means algorithm.
RESULTS: In the SA, the mean composite score was -0.31 (Sd. = 0.58). Most participants presented a negative discourse (n = 41; 72%). Word Count (WC) and Largest Strongly connected Component (LSC) positively correlated with education. No statistically significant correlations were observed between pain intensity, disability levels, SA, and network analysis. Two clusters were identified in our sample.
CONCLUSION: The SA showed that participants reported their feeling when describing the moment of the diagnosis using sentences with negative discourse. We did not find a statistically significant correlation between pain intensity, disability levels, SA, and network analysis. Education level presented positive correlation with WC and LSC.
Enterotoxigenic Escherichia coli (ETEC) strains are significant contributors to postweaning diarrhea in piglets. Of the ETEC causing diarrhea, K88 and F18 accounted for 92.7%. Despite the prevalence of ETEC K88 and F18, there is currently no effective vaccine available due to the diversity of these strains. This study presents an innovative approach by isolating chicken-derived single-chain variable fragment antibodies (scFvs) specific to K88 and F18 fimbrial antigens from chickens immunized against these ETEC virulence factors. These scFvs effectively inhibited adhesion of K88 and F18 to porcine intestinal epithelial cells (IPEC-J2), with the inhibitory effect demonstrating a dose-dependent increase. Furthermore, a bispecific scFv was designed and expressed in Pichia pastoris. This engineered construct displayed remarkable potency; at a concentration of 25.08 μg, it significantly reduced the adhesion rate of ETEC strains to IPEC-J2 cells by 72.10% and 69.11% when challenged with either K88 or F18 alone. Even in the presence of both antigens, the adhesion rate was notably decreased by 57.92%. By targeting and impeding the initial adhesion step of ETEC pathogenesis, this antibody-based intervention holds promise as a potential alternative to antibiotics, thereby mitigating the risks associated with antibiotic resistance and residual drug contamination in livestock production. Overall, this study lays the groundwork for the development of innovative treatments against ETEC infections in piglets.
During the administration of epidural anesthesia, it is recommended that a test dose of Bupivacaine Hydrochloride and Epinephrine Injection without antimicrobial preservative (0.5% bupivacaine with 1:200,000 epinephrine) be administered initially and the effects monitored before the full dose is given. When using a “continuous” catheter technique, test doses should be given prior to both the initial and all supplemental doses, because a catheter in the epidural space can migrate into a blood vessel or through the dura [see Dosage and Administration (2.4)].

During epidural administration, administer Bupivacaine Hydrochloride Injection/Bupivacaine Hydrochloride and Epinephrine Injection, 0.5% (5 mg/mL) and Bupivacaine Hydrochloride Injection 0.75% (7.5 mg/mL) solutions in incremental doses of 3 mL to 5 mL with sufficient time between doses to detect toxic manifestations of unintentional intravascular or intrathecal injection. Administer injections slowly, with frequent aspirations before and during the injection to avoid intravascular injection. Perform syringe aspirations before and during each supplemental injection in continuous (intermittent) catheter techniques. In obstetrics, use ONLY the 0.5% (5 mg/mL) and 0.25% (2.5 mg/mL) concentrations of Bupivacaine Hydrochloride Injection/Bupivacaine Hydrochloride and Epinephrine Injection [see Warnings and Precautions (5.1)]; incremental doses of 3 mL to 5 mL of the 0.5% (5 mg/mL) solution not exceeding 50 mg to 100 mg at any dosing interval are recommended. Repeat doses should be preceded by a test dose containing epinephrine if not clinically contraindicated. Use only the single-dose vials for caudal or epidural anesthesia; avoid use of the multiple-dose vials for these procedures, which contain a preservative [see Dosage and Administration (2.1, 2.4), Warnings and Precautions (5.4, 5.9)].
OBJECTIVE: Acinetobacter baumannii (A. baumannii) causes serious nosocomial infections, especially in Intensive Care Units (ICU). Studies have shown that magnesium (Mg) levels change in sepsis. This study aimed to investigate the effect of Mg levels on mortality in patients with A. baumannii sepsis in the ICU.
PATIENTS AND METHODS: 140 patients who were hospitalized in the tertiary ICU between January 2018 and March 2020 and who were found to have A. baumannii sepsis in their culture follow-ups were included in the study. Demographic information of the patients, Mg levels during hospitalization and follow-up, and various data in the ICU were recorded.
RESULTS: The factors that predicted one-month mortality were old age, APACHE II score, CCIS, A. baumannii detection in the early stages of ICU admission, and high Mg level on day A. baumannii was detected, and the lowest Mg level after A. baumannii was detected in the early period. According to the multivariate logistic regression analysis, age increase [OR (95% CI): 1.062 (1.009-1.117)], APACHE II increase [OR (95% CI): 1.251 (1.141-1.372)], and early detection of A. baumannii during ICU admission [OR (95% CI): 0.902 (0.845-0.962)] were found to be factors that increase one-month mortality.
CONCLUSIONS: Hypermagnesemia in patients with A. baumannii indicates longer-term mortality, while a rapid decrease in Mg levels is a predictor of early mortality. Keeping Mg levels of patients within the reference range with frequent Mg measurement reduces mortality. Knowing colonized patients during admission to the ICU may be useful as an indicator of A. baumannii infection development and mortality risk.
1. Technical Result Production of novel effective antibodies causing humoral immune responses.         2. Essence There is provided novel chimerized anti-human CD40 monoclonal antibody, which blocks the interaction between gp39 and CD40 and is effective in modulating humoral immune responses against T cell-dependent antigens, collagen induced arthritis, and skin transplantation.         3. Field of Application Immunology, medicine.
<P>PROBLEM TO BE SOLVED: To provide a body fat synthesis inhibitor which comprises an inexpensive, easily available compound and is orally ingested to suppress synthesis and accumulation of excessive body fat, wherein the compound is free of safety concerns because it is contained in food with long history of food use and hardly has any side effect.  <P>SOLUTION: The synthesis and accumulation of the excessive body fat are suppressed through oral ingestion of the body fat synthesis inhibitor comprising at least one compound chosen from acetic acid and an acetate. The body fat synthesis inhibitor preferably contains the acetate, especially calcium acetate. The body fat synthesis inhibitor is used as food or pharmaceutical and is provided in the form of e.g. a capsule or a tablet.  <P>COPYRIGHT: (C)2006,JPO&NCIPI
The invention relates to a method for preparing Licardipine Hydrochloride slow-release agent, which can be used to treat hypertension, coronary disease or the like. The inventive slow-release agent is formed by quick-release stomach-soluble micro drop and slow-release enteric-soluble micro drop at 1:0.5-5 ratios in the hollow capsule. The inventive capsule has slow-release effect in 12 hours. The slow-release enteric-soluble micro drop comprises Licardipine Hydrochloride, medical macromolecule materials, drug release adjusting agent and some medical finding. The micro drops are prepared by extruding-rolling technique. The invention can quickly approach the blood drug density to treatment object and hold the density stably, with low side effect.
In 1876, Bennett George Johns, a minister and chaplain at the school for the blind in St George's Field, published Blind People: Their Works and Ways; with Sketches of the Lives of Some Famous Blind Men. The book provided a window into the lives of the blind in Victorian England, with an emphasis on their education-or lack thereof. Johns was an observer of the blind and sympathetic to their plight. His depictions of schools were dispassionate, yet gently argued for improvement. Rather than rely on pity, he emphasized the benefits of institutionalized life and recounted the extraordinary achievements of four blind men. The creation of heroic historical figures had traditionally been employed to venerate political, military, or religious personages. Its use in shaping public perception of blindness was novel. This paper explores Johns's book as an early example of the innocent, myth-building of the blind and considers whether the process is always harmless.
Drug administration is a common nursing clinical intervention. The nurse ensures patient safety by using compatible administration techniques and being aware of the side effects of medications. Pharmacological agents such as heparins, vaccines, insulin, hormone drugs, etc., are generally inappropriate with oral, intravenous or intamuscular intake. Thereupon, they have to be administered by means of subcutaneous (SC) injection. Subcutaneous medications are injected into the tissue layer between the skin and the muscle that is called subcutaneous tissue where does not have a rich blood supply. Suitable areas for subcutaneous injction application are the lateral aspect of the upper arms, posterior aspect of the upper arms, anterior surface of the thigh, unders the scapulas and abdomen in the umbilical region. For the reason that abdominal region has an excess subcutaneous fat tissue, enough space for repeated injections and less muscle activity, it is highly preferred for subcutaneous injections. The angle of entry of the needle into the tissue depends on the needle length and the thickness of the subcutaneous tissue mass. A 90-degree angle is used if the subcutaneous tissue thicknes is about 5 cm. However, when it is 2.5 cm the angle of a 45-degree angle is recommended. To check whether the needle tip is in the vein or not during the application causes the needle movement in the tissue that then results in vascular damage, bleeding, ecchymosis and hematoma formation. Airlock technique in subcutaneous inections is recommended as it ensures that the entire drug is delivered to the tissue as well as preventing the escape of the drug.
Detailed description of the novel device:

The device mainly distinguishes itself from commercial prostheses thanks to its new type of actuation providing a compact and energy efficient solution to the challenge of ankle-foot actuation. This new actuation method consists of using springs, a servo motor and a locking mechanism, coupled with a sensory network providing intelligence to the robotic device. The AMPfoot 4.0 design is also based on previous research conducted on the AMP-Foot 2. However, it is important to note that in contrast with its preceding designs, the AMP-Foot 4.0 does not provide active propulsion at push-off.

During walking, the AMP-Foot 4.0 working principle is divided into two main logic sequences, i.e. the stance and the swing phase. These two phases are detected by analyzing gyroscope and acceleration measurements from an Inertial Measurement Unit chip. During the stance phase, the ankle performs a dorsi-flexing movement while a plantar-flexing torque is applied at the ankle. The person's gravitational potential energy is stored into elastic potential energy by means of the used spring. It is this spring that provides the plantar-flexing torque required at the ankle as reaction to the movement of the user. Due to the use of a locking system, the prosthesis can adapt its so-called zero torque rest point depending on the slope or stride length of the user. This provides adaptability and therefore greater comfort compared to prostheses with a fixed zero torque rest point. During the swing phase, the locking mechanism unlocks to free the ankle movement. Parallel springs external to the stance system are then activated to reset the foot to its initial position. From that moment, the device is ready for a new step.
Brachial plexus blocks at the interscalene level are frequently chosen by physicians and recommended by textbooks for providing regional anesthesia and analgesia to patients scheduled for shoulder surgery. Published data concerning interscalene single-injection or continuous brachial plexus blocks report good analgesic effects. The principle of interscalene catheters is to extend analgesia beyond the duration of the local anesthetic's effect through continuous infusion, as opposed to a single injection. However, in addition to the recognized beneficial effects of interscalene blocks, whether administered as a single injection or through a catheter, there have been reports of consequences ranging from minor side effects to severe, life-threatening complications. Both can be simply explained by direct mispuncture, as well as undesired local anesthetic spread or misplaced catheters. In particular, catheters pose a high risk when advanced or placed uncontrollably, a fact confirmed by reports of fatal outcomes. Secondary catheter dislocations explain side effects or loss of effectiveness that may occur hours or days after the initial correct function has been observed. From an anatomical and physiological perspective, this appears logical: the catheter tip must be placed near the plexus in an anatomically tight and confined space. Thus, the catheter's position may be altered with the movement of the neck or shoulder, e.g., during physiotherapy. The safe use of interscalene catheters is therefore a balance between high analgesia quality and the control of side effects and complications, much like the passage between Scylla and Charybdis. We are convinced that the anatomical basis crucial for the brachial plexus block procedure at the interscalene level is not sufficiently depicted in the common regional anesthesia literature or textbooks. We would like to provide a comprehensive anatomical survey of the lateral neck, with special attention paid to the safe placement of interscalene catheters.
The disclosure relates to antibodies and fragments that bind to a V-domain Ig Suppressor of T cell Activation (VISTA), and methods of eliciting certain biological responses using the antibodies. Methods of identifying anti-VISTA antibodies capable of eliciting certain biological responses are also included.The disclosure relates to antibodies and fragments that bind to a V-domain Ig Suppressor of T cell Activation (VISTA), and methods of eliciting certain biological responses using the antibodies. Methods of identifying anti-VISTA antibodies capable of eliciting certain biological responses are also included. A method of braking a vehicle having a brake member operatively connected to a wheel and an actuation system operatively connected to the brake member to apply a force thereto. The brake member is actuated when the actuation system applies force thereto. The actuation system actuates the brake member to dispose the brake member in a braking configuration in a slowing state for braking of the wheel responsive to receiving a request for slowing the vehicle. Responsive to receiving a request for immobilizing the vehicle, the brake member is actuated with the actuation system so to be disposed in the braking configuration in a parking state in which the brake member prevents rotation of the wheel. The brake member disposed in the parking state is engaged with a parking lock to thereby prevent the brake member from moving out of the parking state. Braking systems are also disclosed.
The present invention relates to a medicine for promoting the increase of bone substances, which belongs to the field of medicines. The medicine of the present invention is formed in a way that traditional Chinese medicines of ginseng, safflower, radix notoginseng, fortune's drynaria rhizome, himalayan teasel root, tall gastrodia tuber, oyster shell, rhubarb, kusnezoff monkshood root, cucumber seed, etc. are combined firstly and matched with western medicines of calcium hydrophosphate, vitamin C and cod-liver oil simultaneously so as to obtain a medicine combined the traditional Chinese medicines and the western medicines. The medicine of the present invention has the advantages of relatively complemented traditional Chinese medicine and western medicine and obtained functions of tendon relaxation, blood circulation activation, bone substance increasing promotion, pain relief, inflammation reduction, etc. The increase of bone cells can be promoted so as to obtain the function of healing as soon as possible when the medicine is used for treating fracture. The medicine has the function of strengthening bones to old people, and can be used for increasing calcareous substances and preventing halosteresis and fracture. The medicine of the present invention has the advantages of reasonable prescription, no toxic side effect and obvious curative effect, and the total effective rate can reach 98.1%.
Preterm infants are suffered from preterm-related medical sequelae and neurobehavioral problems, which required interdisciplinary intervention. Breast milk is the best nutrition for preterm infants. However, consistent breastfeeding is quite challenging to most mothers of prematurity. The purpose of this study is to investigate the effect of integrative early breastfeeding support and intervention programs on preterm infants' breastfeeding rate, neurobehavioral development, and maternal mental health. Method: The prospective, single-blinded randomized controlled trial would be conducted in National Taiwan University Children's Hospital in Taipei, Taiwan. We would recruit the mother and infant dyad whose gestational age is between 28 weeks and 34 6/7 weeks. The intervention group (n=22) would receive integrative early breastfeeding support and intervention programs, including breastfeeding for premature brochure, group education class, weekly interview, one-by-one breastfeeding consultation (at least once during admission) and online peer group support. The control group (n=22) only receive breastfeeding for premature brochure and routine care. Outcome measure: the growth data (including height, weight and head circumference) and types of feeding data at birth, discharge from hospital, 3- and 6-month-old of corrected age would be collected by medical chart review or by interview. Maternal health condition would evaluate by 3 questionnaires, including Breastfeeding Self-Efficacy Scale, Beck Depression Inventory-II and Maternal Confidence Questionnaire. Neuro-behavioral development would be measured using Neonatal Neurobehavioral Evaluation-Chinese version and Bayley Scales of infant and toddler development 3rd edition at corrected age of 3-month-old and 6-month-old separately. Demographic data, birth history, types of breastfeeding data would be compared with independent t test or χ2 test. The effect of integrative early breastfeeding support and intervention on growth of preterm infants, neurobehavioral development, types of feeding, and maternal health would be conducted by logistic regression analysis.